Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/11654
Title: Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials
Authors: Zoccali, Carmine
Blankestijn, Peter J
Bruchfeld, Annette
Capasso, Giovambattista
Fliser, Danilo
Fouque, Denis
Goumenos, Dimitrios
Ketteler, Markus
Massy, Ziad
Rychlık, Ivan
Jose Soler, Maria
Stevens, Kate
Spasovski, Goce 
Wanner, Christoph
Issue Date: 2019
Publisher: Oxford University Press
Journal: Nephrology Dialysis Transplantation
Abstract: The exclusion of chronic kidney disease (CKD) patients from clinical trials-particularly cardiovascular trials-remains a long-standing, unsolved problem, which prevents the optimization of clinical care in these patients. The situation recalls the insufficient recruitment of women in cardiovascular trials until the 1980s, a problem that was only resolved following regulatory interventions. Regulatory agencies are in a unique position to promote recruitment of CKD patients in clinical trials. The main stakeholders, namely patients' associations and scientific societies, should make major lobbying efforts to persuade these agencies that the issue is an absolute public health priority.
URI: http://hdl.handle.net/20.500.12188/11654
DOI: 10.1093/ndt/gfz023
Appears in Collections:Faculty of Medicine: Journal Articles

Show full item record

Page view(s)

42
checked on Mar 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.